Vitamin D as a Potential Therapy for Multiple Sclerosis: Where Are We?
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system and is caused by an aberrant immune response to myelin sheath. Disease-modifying medications, which mainly aim to suppress such aberrant immune response, have significantly improved MS treatment. However, the di...
Main Authors: | Samiksha Wasnik, Isha Sharma, David J. Baylink, Xiaolei Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/9/3102 |
Similar Items
-
Vitamin D—The Iceberg in Endometriosis—Review and Meta-Analysis
by: Alexandra Ursache, et al.
Published: (2024-01-01) -
The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update
by: Amarpreet Sangha, et al.
Published: (2023-06-01) -
An Update on Vitamin D Metabolism
by: Federica Saponaro, et al.
Published: (2020-09-01) -
Effects of Phototherapy on Free Vitamin D Levels in Ten Patients with Atopic Dermatitis
by: Andrea Elmelid, et al.
Published: (2022-12-01) -
Factors Associated with Serum Vitamin D Metabolites and Vitamin D Metabolite Ratios in Premenopausal Women
by: María José Toribio, et al.
Published: (2021-10-01)